FXR2: A Potential Drug Target Or Biomarker (G9513)

Target Name: FXR2

NCBI ID: G9513

FXR2

FXR2: A Potential Drug Target Or Biomarker

FXR2 (FXR2P) is a protein that is expressed in the liver and has been shown to play a role in the regulation of a variety of cellular processes. Several studies have suggested that FXR2 may be a drug target or biomarker, and research is ongoing to determine its potential utility as a therapeutic agent.

TheFXR2 protein is a member of the transforming growth factor-beta (TGF-β) family, which is known for its role in cell proliferation and differentiation. FXR2 has been shown to be involved in the regulation of cellular processes such as cell adhesion, migration, and invasion.

One of the key functions of FXR2 is its role in the regulation of angiogenesis, the process by which new blood vessels are formed. FXR2 has been shown to play a negative role in angiogenesis, by regulating the growth and survival of blood vessels that are attempting to form in the body.

In addition to its role in angiogenesis, FXR2 has also been shown to be involved in the regulation of cellular signaling pathways. For example, FXR2 has been shown to play a role in the regulation of the Notch signaling pathway, a pathway that is involved in the regulation of cellular processes such as stem cell proliferation and differentiation.

Several studies have suggested that FXR2 may be a drug target or biomarker, with potential utility as a therapeutic agent. For example, some researchers have suggested that FXR2 may be a potential target for anti-angiogenic drugs, such as those that are designed to inhibit the formation of new blood vessels. Additionally, FXR2 has been shown to play a role in the regulation of cellular signaling pathways, which may make it a potential target for drugs that are designed to modulate these pathways.

While more research is needed to fully understand the potential utility of FXR2 as a drug target or biomarker, studies are ongoing to determine its potential impact on cellular processes and to explore its potential as a therapeutic agent.

Protein Name: FMR1 Autosomal Homolog 2

Functions: mRNA-binding protein that acts as a regulator of mRNAs translation and/or stability, and which is required for adult hippocampal neurogenesis (By similarity). Specifically binds to AU-rich elements (AREs) in the 3'-UTR of target mRNAs (By similarity). Promotes formation of some phase-separated membraneless compartment by undergoing liquid-liquid phase separation upon binding to AREs-containing mRNAs: mRNAs storage into membraneless compartments regulates their translation and/or stability (By similarity). Acts as a regulator of adult hippocampal neurogenesis by regulating translation and/or stability of NOG mRNA, thereby preventing NOG protein expression in the dentate gyrus (By similarity)

The "FXR2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FXR2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets